Surgery Partners (NASDAQ: SGRY) Earnings Preview Amidst Take-Private Merger Proposal

• Surgery Partners is expected to report earnings on November 9, 2026, with Wall Street estimating earnings of $0.11 per share and revenue of $821 million.
• The company faces a proposed take-private merger with Bon Secours Mercy Health, where shareholders (excluding Bain Capital) would receive $23.50 per share in cash.
• Key financial ratios include a price-to-earnings ratio of -33.62, a price-to-sales ratio of 0.89, and a debt-to-equity ratio of 2.40.

Surgery Partners (NASDAQ: SGRY) operates surgical facilities. The company is expected to report earnings before the market opens on November 9, 2026. Wall Street estimates earnings of about $0.11 per share and revenue of approximately $821 million.

The report comes as Surgery Partners faces a proposed take-private merger with Bon Secours Mercy Health. Under the deal, shareholders other than its largest stockholder, Bain Capital, would receive $23.50 per share in cash. Bain would keep its stake by rolling its equity into the private company.

Bleichmar Fonti & Auld LLP says it is investigating whether the deal involves breaches of fiduciary duty, which are failures to act in shareholders’ interests. The announcement does not report a movement in Surgery Partners’ share price.

Surgery Partners’ price-to-earnings ratio is approximately -33.62, and its earnings yield is -2.96%. Both figures are negative because they are based on a net loss. Its price-to-sales ratio is 0.89, while its enterprise-value-to-sales ratio is 2.02. Enterprise value includes debt as well as the value of its shares.

Surgery Partners’ enterprise-value-to-operating-cash-flow ratio is 26.32, comparing its total business value with cash generated from operations. Its debt-to-equity ratio is 2.40, showing debt relative to shareholder equity. Its current ratio is 1.95, meaning short-term assets are 1.95 times short-term liabilities.